Skip to main content
. 2018 Oct 8;23(10):2568. doi: 10.3390/molecules23102568

Figure 4.

Figure 4

Compound 2 ameliorate TGF-β1-induced myofibroblast differentiation in alveolar epithelial A549 cells. A549 cells were treated with TGF-β1 (2 ng/mL) and compound 2 for 48 h. (A) Cytotoxicity of compound 2 in A549 cells was measured by WST-1 assay at 48h. Compound 2 was treated to A549 cells. (B) The protein expression of α-SMA and N-cadherin was analyzed by western blot. (C) Expression of collagen (Col1A1) and fibronectin was analyzed by qPCR-analysis. All the assays were performed in triplicate, and the data are shown as the mean values ± S.D. Values that are significantly different from the control are indicated by ### p < 0.001, and values that are significantly different from the TGF-β1-treated group are indicated by *** p < 0.001.